Damora Therapeutics, Inc.
DMRAFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Damora Therapeutics, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 7 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Apr 1, 2026. The latest institutional report shown is dated Jun 30, 2024; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| MORGAN STANLEY | 2024-06-30 | 3,000 | Not shown | SEC filing |
| JPMORGAN CHASE & CO | 2024-06-30 | 2,962 | Not shown | SEC filing |
| JPMORGAN CHASE & CO | 2024-06-30 | 2,962 | Not shown | SEC filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2024-06-30 | 214,134 | Not shown | SEC filing |
| RENAISSANCE TECHNOLOGIES LLC | 2024-06-30 | 579,300 | Not shown | SEC filing |
| COMMONWEALTH EQUITY SERVICES, LLC | 2024-06-30 | 16,027 | Not shown | SEC filing |
| BlackRock Inc. | 2024-06-30 | 21,205 | Not shown | SEC filing |
| STATE STREET CORP | 2024-06-30 | 44,906 | Not shown | SEC filing |
| CITADEL ADVISORS LLC | 2024-06-30 | 128,584 | Not shown | SEC filing |
| MORGAN STANLEY | 2024-06-30 | 3,000 | Not shown | SEC filing |
| Tower Research Capital LLC (TRC) | 2024-06-30 | 3,517 | Not shown | SEC filing |
| GROUP ONE TRADING, L.P. | 2024-06-30 | 68 | Not shown | SEC filing |
| Virtu Financial LLC | 2024-06-30 | 14,678 | Not shown | SEC filing |
| Spire Wealth Management | 2024-06-30 | 2,018 | Not shown | SEC filing |
| MORGAN STANLEY | 2024-06-30 | 3,000 | Not shown | SEC filing |
| NORTHERN TRUST CORP | 2024-06-30 | 35,639 | Not shown | SEC filing |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2024-06-30 | 168,352 | Not shown | SEC filing |
| HARBOUR INVESTMENTS, INC. | 2024-06-30 | 200 | Not shown | SEC filing |
| TWO SIGMA SECURITIES, LLC | 2024-06-30 | 27,136 | Not shown | SEC filing |
| Royal Bank of Canada | 2024-06-30 | 193 | Not shown | SEC filing |
- Each value is checked against Damora Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 20 rows: no share price from within three months of their report dates is on file, so they could not be checked.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- HARBOUR INVESTMENTS, INC.: 200 shares reported 2024-03-31; 200 shares reported 2024-06-30.
- JPMORGAN CHASE & CO: 849 shares reported 2023-12-31; 2,962 shares reported 2024-03-31.
19 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Damora Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2023-08-15 · ORBIMED ADVISORS LLC: Larger than 43 of the 44 other insider sales of Common Stock on file. SEC filing
- 2023-08-15 · ORBIMED ADVISORS LLC: Larger than all 44 other insider sales of Common Stock on file. SEC filing
- 2023-07-31 · ORBIMED ADVISORS LLC: Larger than 42 of the 44 other insider sales of Common Stock on file. SEC filing
- 2023-07-13 · ORBIMED ADVISORS LLC: Larger than 41 of the 44 other insider sales of Common Stock on file. SEC filing
- 2023-04-05 · ORBIMED ADVISORS LLC: Larger than 40 of the 44 other insider sales of Common Stock on file. SEC filing
- 2022-03-22 · Lindmark Bertil: Larger than 10 of the 11 other insider purchases of Common Stock on file. SEC filing
- 2020-11-02 · Christgau Stephan: Larger than all 11 other insider purchases of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2022-03-22–2022-03-22: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2021-12-03–2021-12-03: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2021-11-08–2021-11-09: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2021-06-23–2021-06-28: 4 event(s) across 4 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
- 2020-11-02–2020-11-02: 4 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-01-02 | Winslow Garrett · General Counsel | Common Stock | S — Open market or private sale | −255 | 21.38 | SEC filing |
| 2026-01-02 | Firmani Lori · Chief Financial Officer | Common Stock | S — Open market or private sale | −135 | 21.41 | SEC filing |
| 2026-01-02 | Schambye Hans T. · Chief Executive Officer | Common Stock | S — Open market or private sale | −700 | 21.38 | SEC filing |
| 2025-07-03 | Winslow Garrett · General Counsel | Common Stock | S — Open market or private sale | −260 | 3.39 | SEC filing |
| 2025-07-03 | Schambye Hans T. · Chief Executive Officer | Common Stock | S — Open market or private sale | −735 | 3.38 | SEC filing |
| 2025-07-03 | Firmani Lori · Interim CFO | Common Stock | S — Open market or private sale | −147 | 3.39 | SEC filing |
| 2025-01-03 | Firmani Lori · Interim CFO | Common Stock | S — Open market or private sale | −261 | 5.63 | SEC filing |
| 2025-01-03 | Winslow Garrett · General Counsel | Common Stock | S — Open market or private sale | −471 | 5.60 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-03-30 | Jarrett Jennifer · See Remarks | Stock Option (right to buy) | A — Grant, award, or other acquisition | +1,500,000 | SEC filing |
| 2026-03-30 | Jarrett Jennifer · See Remarks | Common Stock | A — Grant, award, or other acquisition | +500,000 | SEC filing |
| 2026-03-23 | Landsittel Michael · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +37,313 | SEC filing |
| 2026-03-23 | Bruno Julianne · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +37,313 | SEC filing |
| 2026-03-23 | Harwin Peter Evan · Director, 10% owner | Stock Option (right to buy) | A — Grant, award, or other acquisition | +37,313 | SEC filing |
| 2026-03-23 | Winslow Garrett · General Counsel | Stock Option (right to buy) | A — Grant, award, or other acquisition | +250,000 | SEC filing |
| 2026-03-23 | Turtle Cameron · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +37,313 | SEC filing |
| 2026-03-23 | CAIN CHRISTOPHER W. · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +37,313 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.